+1 (202) 780-3397
Commentary - Asian Journal of Biomedical and Pharmaceutical Sciences (2020) Volume 10, Issue 70
Commentary on treatment patterns among recurrent/metastatic soft tissue sarcoma by medical oncologists
As new antitumor drugs to soft tissue sarcoma (STS) have been approved, clinical data about the patterns of treatment of STS patients were reported from many Western countries, but those from Asia were lacking. We retrospectively reviewed the clinical records of 273 STS patients consulted medical oncologists in the multidisciplinary team in the cancer center, and the data might help considering treatment strategies to STS patients.
Author(s): Kenji Nakano